XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2
Shareholders Equity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 11, 2021
shares
Jun. 30, 2024
USD ($)
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
D
shares
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
May 27, 2021
$ / shares
shares
Shareholders' Equity              
Conversion, threshold percentage of market price   95.00%   95.00%      
Gain (loss) recognized for the change in liability | $   $ 3,915 $ 17,901 $ 9,594 $ 52,215    
0.75% senior exchangeable notes due January 2024              
Shareholders' Equity              
Interest rate (as a percent)           0.75%  
5.75% senior notes due February 2025              
Shareholders' Equity              
Interest rate (as a percent)           5.75%  
7.25% senior notes due January 2026              
Shareholders' Equity              
Interest rate (as a percent)   7.25%   7.25%      
Common share warrants              
Shareholders' Equity              
Number of warrants received per common share held             0.40
Number of warrants issued 3,200,000            
Number of business day notice period | D       20      
Fair value of outstanding warrants | $   $ 16,300   $ 16,300   $ 25,900  
Warrants outstanding   2,500,000   2,500,000      
Common share warrants | Other, net              
Shareholders' Equity              
Gain (loss) recognized for the change in liability | $   $ 3,900 $ 17,900 $ 9,600 $ 52,200    
Common Shares              
Shareholders' Equity              
Aggregate number of shares issued from the exercise of warrants   1,100,000   1,100,000      
Number of shares which may be purchased by each right             1
Exercise price (in dollars per share) | $ / shares             $ 166.66667